Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Results: Aquacel Hypersensitivity Dressing in TJAs [Phase 4]
Phase 4 trial results for Aquacel Hypersensitivity Dressing in total joint arthroplasty evaluating contact allergic dermatitis and adverse s…
-
FDA label_change · 2026-03-16FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Comparing Tissue Adhesives in Port Site Closure [Phase 3]
A Phase 3 clinical trial comparing tissue adhesives for port-site closure has completed. The study involved conditions related to contact de…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Methotrexat to Hand Eczema in the BIOSKIN Cohort
The BIOSKIN cohort is evaluating methotrexate for hand eczema in patients with atopic dermatitis and contact dermatitis, with the study curr…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction [NA]
A clinical trial is evaluating a novel skin barrier product against petrolatum for skin barrier dysfunction and is currently recruiting at M…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: DermAI to Evaluate Human Factor of Testing [NA]
A Mayo Clinic-sponsored clinical trial evaluating human factors in DermAI testing for contact dermatitis has completed and posted results.
-
FDA approval · 2025-07-18FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Fluocinonide Acetonide Oil, a topical corticosteroid product from Rising Pharma Holdings, In…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement [NA]
A completed clinical trial evaluated the effect of a marula-derived ceramide cream on skin barrier function across several skin conditions, …
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters [NA]
A post-marketing clinical follow-up study is evaluating the performance and safety of the 047 TD Dermatitis Cream in adults and children wit…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Diagnostic Accuracy of Teledermatology in Patch Test Interpretation [NA]
This update reports the results of a completed study evaluating how accurately teledermatology can interpret patch test results in diagnosin…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population [NA]
A NICU-focused clinical trial evaluated the use of coconut oil for the prevention and treatment of diaper dermatitis. The study is completed…
-
FDA approval · 2024-08-22FDA Approved: BETAMETHASONE VALERATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Betamethasone Valerate topical (Alembic Pharmaceuticals), a generic corticosteroid product for inflammator…
-
FDA approval · 2022-02-18FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a…
-
FDA approval · 2022-02-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the original application for a generic clobetasol propionate topical product by Quagen Pharmaceuticals LLC.
-
FDA approval · 2021-04-02FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the Original Application for fluocinonide acetonide topical product. The generic is manufactured by Quagen Pharmaceuticals LLC.
-
FDA approval · 2020-08-28FDA Approved: CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% — Original Application (Northstar Rx LLC)
FDA approved Northstar Rx LLC's generic clobetasol propionate cream 0.05% (ANDA212982), a potent topical corticosteroid indicated for inflam…
-
FDA approval · 2020-08-27FDA Approved: HALOBETASOL PROPIONATE — Supplemental Application (Coral Way Pharma, LLC)
FDA approved a supplemental application for halobetasol propionate filed by Coral Way Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Clinical Evaluation of Lyral® Dose Response Study [Phase 2]
Phase 2 clinical trial evaluating Lyral dose response for contact dermatitis has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study [Phase 2]
Phase 2 clinical trial evaluating dose response of metal panel allergens (mercury, aluminum, palladium) for contact dermatitis; completed wi…
-
FDA approval · 2020-06-15FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., indicating an approval related to the gene…
-
FDA approval · 2020-01-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic clobetasol propionate topical product under an original application, expanding access…
-
FDA approval · 2019-11-29FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals' Triamcinolone Acetonide Ointment USP, 0.05% as an original generic topical corticosteroid product through …
-
FDA approval · 2019-11-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for clobetasol propionate topical, a potent corticosteroid, for inflammatory and …
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for clobetasol propionate topical, a high-potency corticosteroid, enabli…